ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áø·á°ú ¾È³»
[¹®ÀÇÀüÈ] 1577-9966
Áø·á°ú¸¦ ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Áø·á°úÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°£¼¾ÅÍ
-
[SCI]
Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
/ Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
/ 201607
-
[SCI]
Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells
/ Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells
/ 201511
-
[SCI]
Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma
Sohn BH, Shim JJ, Kim SB, Jang KY, Kim SM, Kim JH, Hwang JE, Jang HJ, Lee HS, Kim SC, Jeong W, Kim SS, Park ES, Heo J, Kim YJ, Kim DG, Leem SH, Kaseb AO, Hassan MM, Cha M, Chu IS, Johnson R, Park YY, Lee JS
/ Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma
/ 201510
-
[SCI]
Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
Kim HS, Yim HJ, Jang MK, Park JW, Suh SJ, Seo YS, Kim JH, Kim BH, Park SJ, Lee SH, Kim SG, Kim YS, Lee JI, Lee JW, Kim IH, Kim TY, Kim JW, Jeong SH, Jung YK, Park H, Hwang SG
/ Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
/ 21(38):10874-82
/ 201510
-
[SCI]
The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Yim SY, Seo YS, Jung CH, Kim TH, Lee JM, Kim ES, Keum B, Jong YK, An H, Kim JH, Yim HJ, Kim DS, Jeen YT, Yeon JE, Lee HS, Chun HJ, Byun KS, Um SH, Kim CD, Ryu HS
/ The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
/ 201509